Filing Details
- Accession Number:
- 0001415889-25-000995
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-07 16:14:03
- Reporting Period:
- 2025-01-06
- Accepted Time:
- 2025-01-07 16:14:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1159036 | Halozyme Therapeutics Inc. | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1324015 | William Jeffrey Henderson | C/O Halozyme Therapeutics, Inc. 12390 El Camino Real San Diego CA 92130 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-06 | 10,000 | $50.01 | 43,611 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 17, 2024 in accordance with Rule 10b5-1.
- Represents a weighted average sales price per share. The shares were sold at prices ranging from $50.00 to $50.11. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Billionaire Hedge Funds
